HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simone Difilippantonio Selected Research

Rhabdomyosarcoma

8/2023Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
1/2023The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
1/2018MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simone Difilippantonio Research Topics

Disease

23Neoplasms (Cancer)
04/2024 - 11/2012
7Neoplasm Metastasis (Metastasis)
02/2024 - 05/2018
5Brain Neoplasms (Brain Tumor)
02/2024 - 01/2018
5Breast Neoplasms (Breast Cancer)
02/2024 - 01/2018
4Genomic Instability
06/2022 - 06/2003
3Rhabdomyosarcoma
08/2023 - 01/2018
3Ataxia Telangiectasia (Louis Bar Syndrome)
11/2008 - 09/2006
2Body Weight (Weight, Body)
03/2023 - 01/2023
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 01/2018
2Plasmacytoma
12/2008 - 08/2004
2Lymphoma (Lymphomas)
12/2008 - 11/2005
1Ewing Sarcoma (Sarcoma, Ewing)
04/2024
1Communicable Diseases (Infectious Diseases)
01/2024
1Inflammation (Inflammations)
01/2024
1Autoimmune Diseases (Autoimmune Disease)
01/2024
1Infections
12/2023
1Renal Cell Carcinoma (Grawitz Tumor)
04/2023
1Neoplasm Micrometastasis
01/2023
1Malignant Mesothelioma
06/2022
1Microsatellite Instability
06/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Gliosis
01/2021
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2020
1Diarrhea
01/2020
1Fibrosis (Cirrhosis)
05/2018
1Carcinoma (Carcinomatosis)
01/2018
1Leukemia
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2014
1Sarcoma (Soft Tissue Sarcoma)
10/2013

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
04/2024 - 09/2006
4VaccinesIBA
12/2023 - 01/2021
4Phosphotransferases (Kinase)IBA
01/2023 - 07/2007
3AntibodiesIBA
01/2024 - 11/2020
3Immunoconjugates (Immunoconjugate)IBA
11/2023 - 11/2020
3Histones (Histone)IBA
01/2018 - 06/2003
2biocytinIBA
02/2024 - 01/2023
2Sirolimus (Rapamycin)FDA Link
04/2023 - 11/2012
2trametinibIBA
01/2023 - 01/2018
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 01/2018
2Dextrans (Dextran)FDA Link
01/2022 - 01/2018
2Topotecan (Hycamtin)FDA LinkGeneric
01/2020 - 01/2018
2indimitecanIBA
01/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2014 - 08/2012
1Etoposide (VP 16)FDA LinkGeneric
04/2024
1DNA-Activated Protein KinaseIBA
04/2024
1AZD7648IBA
04/2024
1Immunoglobulin G (IgG)IBA
02/2024
1Trastuzumab (Herceptin)FDA Link
02/2024
1AutoantigensIBA
01/2024
1pyrrolo(2,1-c)(1,4)benzodiazepineIBA
11/2023
1futibatinibIBA
08/2023
1glembatumumab vedotinIBA
04/2023
1mithramycin AIBA
04/2023
18- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA
04/2023
1Microphthalmia-Associated Transcription FactorIBA
04/2023
1AlbuminsIBA
01/2023
1neonatal Fc receptorIBA
01/2023
1ganitumabIBA
01/2023
1ClathrinIBA
01/2023
1GlycosphingolipidsIBA
01/2023
1Peptides (Polypeptides)IBA
01/2023
1Galectin 3 (LGALS3)IBA
01/2023
1Liposomes (Liposome)IBA
10/2022
1MMEIBA
06/2022
1AsbestosIBA
06/2022
1Monoclonal AntibodiesIBA
01/2022
1Neurofibromin 2 (Merlin)IBA
01/2021
1Semaphorin-3AIBA
01/2021
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2021
1Papillomavirus Vaccines (HPV Vaccines)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1human ERBB2 proteinIBA
11/2020
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2020
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2020
1CamptothecinIBA
01/2020
1LMP517IBA
01/2020
1Irinotecan (Camptosar)FDA LinkGeneric
01/2020
1tyrosyl-DNA phosphodiesteraseIBA
01/2020
1NSC 724998IBA
01/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020
1Lysophosphatidic Acid ReceptorsIBA
05/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Mitogen-Activated Protein KinasesIBA
01/2018
1Phosphates (Orthophosphate)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Coloring Agents (Dyes)IBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2014
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2014
1olaparibIBA
01/2014
1PlatinumIBA
01/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2013
1TensinsIBA
10/2013
1Retinoblastoma ProteinIBA
10/2013
1AfatinibIBA
11/2012

Therapy/Procedure

9Therapeutics
01/2024 - 11/2012
3Drug Therapy (Chemotherapy)
04/2024 - 01/2014
2Intravenous Administration
03/2023 - 01/2023
1Immunotherapy
01/2023